Eli Lilly & Co. (NYSE: LLY) has accepted the recommendation of the ACCELERATE study data monitoring committee to continue the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE